Outlook Therapeutics
OTLK
OTLK
63 hedge funds and large institutions have $8.64M invested in Outlook Therapeutics in 2025 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 24 increasing their positions, 14 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
3% more funds holding
Funds holding: 61 → 63 (+2)
1% more capital invested
Capital invested by funds: $8.59M → $8.64M (+$57.6K)
Holders
63
Holding in Top 10
–
Calls
$74K
Puts
$32K
Top Buyers
| 1 | +$1.89M | |
| 2 | +$1.05M | |
| 3 | +$447K | |
| 4 |
TCM
Tang Capital Management
San Diego,
California
|
+$265K |
| 5 |
BlackRock
New York
|
+$182K |
Top Sellers
| 1 | -$286K | |
| 2 | -$246K | |
| 3 | -$234K | |
| 4 |
RhumbLine Advisers
Boston,
Massachusetts
|
-$210K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$190K |
